Sept 23 (Reuters) – FDA: * FDA: DIRECTED TAKEDA PHARMACEUTICALS TO ADD BOXED WARNING, ON DRUG LABEL, TO ADZYNMA'S PRESCRIBING INFORMATION Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
(Changes attribution to HHS statement in paragraph 7) Sept 23 (Reuters) - The US Food…
SINGAPORE, Sept 24 (Reuters) - Southeast Asia is developing more than 100 gigawatts of gas-fired…
By Kenrick Cai SAN FRANCISCO, Sept 23 (Reuters) - The founder of the trust and…
By Kenrick Cai SAN FRANCISCO, Sept 23 (Reuters) - The founder of the trust and…
By Doyinsola Oladipo NEW YORK, Sept 23 (Reuters) - Sudan on Wednesday said it "upholds…
(Adds warning from mayor, emergency crews dispatched to three districts) Sept 24 (Reuters) - The…